|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Calctriol Capsules, 0.25 mcg and 0.5 mcg, Teva USA ANDA 75-765 10/12/01 4/15/03
Calcitriol Injection, 0.001 mg/mL, Lyne ANDA 76-206 9/17/03
Calcitriol Injection, 0.001 mg/mL, Lyne ANDA 76-206 8/22/03
Calcitriol Injection, 0.001 mg/mL & 0.002 mg/mL, American Pharmaceutical Partners, ANDA 75-836 12/31/02
Calcitriol Injection, 0.001 mg/mL & 0.002 mg/mL, Gensia Sicor ANDA 75-823 1/2/03
Calcitriol Injection, 0.001 mg/mL & 0.002 mg/mL, Faulding Pharmaceutical Co. ANDA 75-816 12/31/02
Calcitriol Injection, 0.001 mg/mL & 0.002 mg/mL, aaiPharma ANDA 75-766 2/20/03
Calcitriol Injection, 0.001 mg/mL & 0.002 mg/mL, Luitpold ANDA 75-746 9/26/03
Calcitriol Injection, 0.001 mg/mL & 0.002 mg/mL, Luitpold ANDA 75-746 1/12/03
Calcitriol Solution, 1 mcg/mL, Roxane ANDA 76-242 Rocaltrol (calcitriol) Capsules & Solution, Hoffmann-LaRoche NDA 18-044/S28 & 21-068/S1 2/1/02 4/17/02
Rocaltrol (calcitriol)1mcg/mL oral solution Hoffman LaRoche NDA 21-068 and 18-044/S-025 11/20/98 11/20/98
Rocaltrol (calcitriol) Solution (3S) Roche Biolscience NDA 21-068 11/20/98 11/23/98 11/23/98 7/4/99
Rocaltrol Indication: Indication is for the management of secondary hyperparathyroidism and resultant metabolic bone disease in predialysis (moderate to severe chronic renal failure) patients (adults, neonates, and older infants). CALCITRIOL Capsule; 0.25UGM ROCALTROL ROCHE
018044 CALCITRIOL Capsule; 0.5UGM ROCALTROL ROCHE
075765 CALCITRIOL Capsule; 0.25UGM CALCITRIOL Teva
075765 CALCITRIOL Capsule; 0.5UGM CALCITRIOL Teva
075766 CALCITRIOL Injection 0.001MG/ML CALCITRIOL AAIPHARMA 075766 CALCITRIOL Injection 0.002MG/ML CALCITRIOL AAIPHARMA 018874 CALCITRIOL Injection 0.001MG/ML CALCIJEX Abbott 018874 CALCITRIOL Injection 0.002MG/ML CALCIJEX Abbott 075836 CALCITRIOL Injection 0.001MG/ML CALCITRIOL AM PARTNERS
075836 CALCITRIOL Injection 0.002MG/ML CALCITRIOL AM PARTNERS
075823 CALCITRIOL Injection 0.001MG/ML CALCITRIOL Gensia Sicor 075823 CALCITRIOL Injection 0.002MG/ML CALCITRIOL Gensia Sicor 075746 CALCITRIOL Injection 0.001MG/ML CALCITRIOL LUITPOLD
075746 CALCITRIOL Injection 0.002MG/ML CALCITRIOL LUITPOLD
076206 CALCITRIOL Injection 0.001MG/ML CALCITRIOL Lyne
021068 CALCITRIOL Solution; 1UGM/ML ROCALTROL ROCHE
076242 CALCITRIOL Solution; 1UGM/ML CALCITRIOL Roxane Calcitriol Injection, Mayne Pharma Rocaltrol (calcitriol) Capsules, Hoffmann-La Roche Inc., Labeling Revision
Rocaltrol (calcitriol) Oral Solution, Hoffmann-La Roche Inc., Labeling Revision | Calcitriol Capsule, Roxane Labs, Approval
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|